Iqvia Holdings (IQV) Net Income towards Common Stockholders (2012 - 2026)
Iqvia Holdings' (IQV) quarterly Net Income towards Common Stockholders came in at $141.0 million in Q1 2026, down 44.49% year-on-year from $254.0 million in Q1 2025, and down 59.83% quarter-over-quarter from $351.0 million in Q4 2025.
Iqvia Holdings (IQV) Net Income towards Common Stockholders (2012 - 2026) Analysis & Trends
Iqvia Holdings has disclosed Net Income towards Common Stockholders across 15 years of filings, most recently posting $141.0 million for Q1 2026.
- Net Income towards Common Stockholders for Q1 2026 came in at $141.0 million, down 44.49% year-over-year; the trailing twelve-month figure through Mar 2026 was $955.0 million (down 28.25% YoY), and the FY2025 annual result was $1.2 billion, down 11.4% from the prior year.
- Net Income towards Common Stockholders came in at $141.0 million for Q1 2026 at Iqvia Holdings, down from $351.0 million in the prior quarter.
- In the past five years, Net Income towards Common Stockholders ranged from a high of $475.0 million in Q4 2023 to a low of $141.0 million in Q1 2026.
- The 5-year median for Net Income towards Common Stockholders is $291.0 million (2023), against an average of $296.4 million.
- Across the five-year window, Net Income towards Common Stockholders jumped 563.38% in 2022 and sank 44.49% in 2026, its largest moves.
- Iqvia Holdings' Net Income towards Common Stockholders stood at $227.0 million in 2022, then surged by 109.25% to $475.0 million in 2023, then retreated by 9.05% to $432.0 million in 2024, then dropped by 18.75% to $351.0 million in 2025, then plunged by 59.83% to $141.0 million in 2026.
- The last three Net Income towards Common Stockholders figures came in at $141.0 million (Q1 2026), $351.0 million (Q4 2025), and $204.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 29,902.70 Bn | 29,902.24 Bn | 1.11 Bn | -72.00 Mn |
| 2 | Thermo Fisher Scientific | 175.99 Bn | 172.74 Bn | 7.74 Bn | 1.66 Bn |
| 3 | Danaher | 129.87 Bn | 124.18 Bn | 3.59 Bn | 1.03 Bn |
| 4 | Idexx Laboratories | 44.75 Bn | 44.55 Bn | 722.74 Mn | 278.45 Mn |
| 5 | Agilent Technologies | 37.52 Bn | 35.72 Bn | 990.00 Mn | 339.00 Mn |
| 6 | Iqvia Holdings | 30.91 Bn | 28.94 Bn | 1.36 Bn | 141.00 Mn |
| 7 | Natera | 30.21 Bn | 29.11 Bn | 696.04 Mn | -85.11 Mn |
| 8 | Illumina | 24.19 Bn | 23.04 Bn | 721.00 Mn | 134.00 Mn |
| 9 | Mettler Toledo International | 23.12 Bn | 23.06 Bn | 555.82 Mn | 169.45 Mn |
| 10 | Quest Diagnostics | 21.68 Bn | 21.59 Bn | 942.00 Mn | -40.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 141.00 Mn |
| Dec 31, 2025 | 351.00 Mn |
| Sep 30, 2025 | 204.00 Mn |
| Jun 30, 2025 | 259.00 Mn |
| Mar 31, 2025 | 254.00 Mn |
| Dec 31, 2024 | 432.00 Mn |
| Sep 30, 2024 | 284.00 Mn |
| Jun 30, 2024 | 361.00 Mn |
| Mar 31, 2024 | 291.00 Mn |
| Dec 31, 2023 | 475.00 Mn |
| Sep 30, 2023 | 298.00 Mn |
| Jun 30, 2023 | 294.00 Mn |
| Mar 31, 2023 | 291.00 Mn |
| Dec 31, 2022 | 227.00 Mn |
| Sep 30, 2022 | 290.00 Mn |
| Jun 30, 2022 | 257.00 Mn |
| Mar 31, 2022 | 329.00 Mn |
| Dec 31, 2021 | 317.00 Mn |
| Sep 30, 2021 | 261.00 Mn |
| Jun 30, 2021 | 174.00 Mn |